HomeRVV • CNSX
add
Revive Therapeutics Ltd
Previous close
$0.010
Day range
$0.015 - $0.015
Year range
$0.0050 - $0.035
Market cap
4.71M CAD
Avg Volume
149.74K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 336.39K | 43.77% |
Net income | -9.60M | -271.19% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -336.32K | -43.79% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.56K | -98.12% |
Total assets | 205.02K | -98.07% |
Total liabilities | 3.66M | 7.54% |
Total equity | -3.46M | — |
Shares outstanding | 423.16M | — |
Price to book | -1.00 | — |
Return on assets | -17.11% | — |
Return on capital | -64.23% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.60M | -271.19% |
Cash from operations | -6.02K | 97.82% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | -25.85K | 35.38% |
Net change in cash | -31.86K | 88.47% |
Free cash flow | -221.91K | -9.73% |
About
Founded
2012
Headquarters
Website
